Quantcast

Latest autoimmune diseases Stories

2014-03-03 08:32:34

CCFA Researchers Map Out Strategies to New Drugs and Individualized Therapy for Crohn's Disease and Ulcerative Colitis NEW YORK, March 3, 2014 /PRNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and...

2014-02-28 23:02:01

DailyGossip.org reveals that multiple sclerosis is a complex condition that causes numerous symptoms. The magazine publishes a review to the Multiple Sclerosis Treatment, the newest natural remedy that provides fast symptoms relief. Denver, CO (PRWEB) February 28, 2014 According to http://www.DailyGossip.org, multiple sclerosis is a condition that can be developed by any individual. The disease is formed when the immune system attacks the protective sheath that covers the nerves. A...

2014-02-26 23:33:54

The new “Autoimmune Disease Treatment” writing on the website Vkool.com covers natural ways to treat autoimmune diseases effectively. Seattle, Wa (PRWEB) February 26, 2014 The new “Autoimmune Disease Treatment” article on the site Vkool.com delivers to readers easy tips to cure autoimmune disorders. The report is divided into two main sections. In the first section of the report, people will get to know common causes of autoimmune diseases, such as family history, hormonal status,...

2014-02-26 08:28:31

OKLAHOMA CITY, Feb. 26, 2014 /PRNewswire/ -- Altheus Therapeutics, Inc., announced completion of dosing in ZA201, a double-blind, active-controlled Phase 2 trial evaluating the efficacy and safety of Zoenasa® Rectal Gel versus mesalamine enema in 120 patients with left-sided ulcerative colitis. The primary endpoint of ZA201 is reduction in the Ulcerative Colitis Disease Activity Index (UCDAI) at 6 weeks. Secondary endpoints include endoscopic remission, reduction in UCDAI at 3...

2014-02-25 08:32:12

EASTBOURNE, England, February 25, 2014 /PRNewswire/ -- Daval International, the emerging life sciences company focused on the development of novel treatments for serious unmet medical needs, today announced receipt of Orphan Drug Designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Products Development, for AIMSPRO(R) for the treatment of systemic sclerosis (scleroderma). "The granting of Daval's request for Orphan Drug Designation represents a...

2014-02-21 16:23:07

PHILADELPHIA, Feb. 21, 2014 /PRNewswire-USNewswire/ -- An antibody found in the blood of people with multiple sclerosis (MS) may be present long before the onset of the disease and its symptoms, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. "If our results can be replicated in larger populations, our findings may help to detect MS earlier in a subgroup of patients," said...

2014-02-20 04:20:55

-- More than 200 artists inspired by patients in more than 40 countries NORTH CHICAGO, Ill., Feb. 20, 2014 /PRNewswire/ -- AbbVie today announced the launch of 'Perspectives - Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases (IMIDs) and their impact on patients and society. More than 100 unique artistic expressions from the initiative are being debuted at the 9th Congress of the...

2014-02-18 08:30:20

PETACH TIKVA, Israel, Feb. 18, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's development plan for 2014. Following a productive 2013, Can-Fite plans to continue its positive momentum in 2014 with further advancement of its drug portfolio, which it believes will translate into growth catalysts poised to drive...

2014-02-11 08:31:33

Company's Proprietary Drug CF101 Well-Positioned to Benefit from a Global RA Drug Market Study Forecasted to Generate Revenues of $38.5 bn in 2017 PETACH TIKVA, Israel, Feb. 11, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today commented on the overall growth of the global rheumatoid arthritis market opportunity and the...

2014-02-06 23:03:43

Paddison Program For Rheumatoid Arthritis designed by Clint Paddison is the latest program that provides a wide range of exercises for pain relief and joint healing. A full review on the site HealthReviewCenter.com indicates if Paddison Program For Rheumatoid Arthritis is worth buying. Seattle, WA (PRWEB) February 06, 2014 Rheumatoid arthritis (RA) is a chronic inflammatory disorder that typically affects the small joints in people’s hands and feet. RA also is a disabling and painful...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related